Literature DB >> 9472022

Vaccinia NPH-I, a DExH-box ATPase, is the energy coupling factor for mRNA transcription termination.

L Deng1, S Shuman.   

Abstract

Vaccinia virus RNA polymerase terminates transcription in response to a specific signal UUUUUNU in the nascent RNA. Transduction of this signal to the elongating polymerase requires a trans-acting viral termination factor (VTF/capping enzyme), and is coupled to the hydrolysis of ATP. Recent studies suggest that ATP hydrolysis is catalyzed by a novel termination protein (factor X), which is tightly associated with the elongation complex. Here, we identify factor X as NPH-I (nucleoside triphosphate phosphohydrolase-I), a virus-encoded DNA-dependent ATPase of the DExH-box family. We report that NPH-I serves two roles in transcription (1) it acts in concert with VTF/CE to catalyze release of UUUUUNU-containing nascent RNA from the elongation complex, and (2) it acts by itself as a polymerase elongation factor to facilitate readthrough of intrinsic pause sites. A mutation (K61A) in the GxGKT motif of NPH-I abolishes ATP hydrolysis and eliminates the termination and elongation factor activities. Related DExH proteins may have similar roles at postinitiation steps during cellular mRNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472022      PMCID: PMC316528          DOI: 10.1101/gad.12.4.538

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  39 in total

1.  Stability of ternary transcription complexes of vaccinia virus RNA polymerase at promoter-proximal positions.

Authors:  J Hagler; S Shuman
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

2.  Methylated nucleotides block 5'-terminus of vaccinia virus messenger RNA.

Authors:  C M Wei; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

3.  Transcription termination factor rho is an RNA-DNA helicase.

Authors:  C A Brennan; A J Dombroski; T Platt
Journal:  Cell       Date:  1987-03-27       Impact factor: 41.582

4.  Two nucleic acid-dependent nucleoside triphosphate phosphohydrolases from vaccinia virus. Nucleotide substrate and polynucleotide cofactor specificities.

Authors:  E Paoletti; B Moss
Journal:  J Biol Chem       Date:  1974-05-25       Impact factor: 5.157

5.  Ribonucleic acid synthesis in vaccinia virus. II. Synthesis of polyriboadenylic acid.

Authors:  J Kates; J Beeson
Journal:  J Mol Biol       Date:  1970-05-28       Impact factor: 5.469

6.  Purification and characterization of a transcription termination factor from vaccinia virions.

Authors:  S Shuman; S S Broyles; B Moss
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

7.  Multiple roles for ATP in the synthesis and processing of mRNA by vaccinia virus: specific inhibitory effects of adenosine (beta,gamma-imido) triphosphate.

Authors:  A Gershowitz; R F Boone; B Moss
Journal:  J Virol       Date:  1978-08       Impact factor: 5.103

8.  An RNA-dependent nucleoside triphosphate phosphohydrolase (ATPase) associated with rho termination factor.

Authors:  C Lowery-Goldhammer; J P Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

9.  Modification of the 5'-terminus of mRNA by soluble guanylyl and methyl transferases from vaccinia virus.

Authors:  M J Ensinger; S A Martin; E Paoletti; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1975-07       Impact factor: 11.205

10.  Identification of the vaccinia virus gene encoding nucleoside triphosphate phosphohydrolase I, a DNA-dependent ATPase.

Authors:  S S Broyles; B Moss
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

View more
  24 in total

1.  Mechanism of poly(A) signal transduction to RNA polymerase II in vitro.

Authors:  D P Tran; S J Kim; N J Park; T M Jew; H G Martinson
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

2.  Role of forward translocation in nucleoside triphosphate phosphohydrolase I (NPH I)-mediated transcription termination of vaccinia virus early genes.

Authors:  Jessica Tate; Paul Gollnick
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

Review 3.  Understanding helicases as a means of virus control.

Authors:  D N Frick; A M I Lam
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

4.  Human capping enzyme promotes formation of transcriptional R loops in vitro.

Authors:  Syuzo Kaneko; Chun Chu; Aaron J Shatkin; James L Manley
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-31       Impact factor: 11.205

5.  The vaccinia virus A18R DNA helicase is a postreplicative negative transcription elongation factor.

Authors:  Y Xiang; D A Simpson; J Spiegel; A Zhou; R H Silverman; R C Condit
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

6.  Vaccinia virus early gene transcription termination factors VTF and Rap94 interact with the U9 termination motif in the nascent RNA in a transcription ternary complex.

Authors:  Linda A Christen; Sarah Piacente; Mohamed R Mohamed; Edward G Niles
Journal:  Virology       Date:  2008-05-01       Impact factor: 3.616

7.  The NPH-II helicase displays efficient DNA x RNA helicase activity and a pronounced purine sequence bias.

Authors:  Sean David Taylor; Amanda Solem; Jane Kawaoka; Anna Marie Pyle
Journal:  J Biol Chem       Date:  2010-01-28       Impact factor: 5.157

8.  Development and validation of a high-density fluorescence polarization-based assay for the trypanosoma RNA triphosphatase TbCet1.

Authors:  Christophe Antczak; David Shum; Constantin Radu; Venkatraman E Seshan; Hakim Djaballah
Journal:  Comb Chem High Throughput Screen       Date:  2009-03       Impact factor: 1.339

9.  Mutational analysis of vaccinia virus nucleoside triphosphate phosphohydrolase I, a DNA-dependent ATPase of the DExH box family.

Authors:  A Martins; C H Gross; S Shuman
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Increased ATP generation in the host cell is required for efficient vaccinia virus production.

Authors:  Chia-Wei Chang; Hui-Chun Li; Che-Fang Hsu; Chiao-Yen Chang; Shih-Yen Lo
Journal:  J Biomed Sci       Date:  2009-09-02       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.